Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy

Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960's. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combi...

Full description

Bibliographic Details
Main Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (-)
Corporate Authors: World Health Organization, International Agency for Research on Cancer
Format: eBook
Language:Inglés
Published: Lyon, France : Geneva : International Agency for Research on Cancer ; Distributed by WHO Press 2007.
Series:IARC monographs on the evaluation of carcinogenic risks to humans ; v. 91.
Subjects:
Progestational hormones > Carcinogenicity.
Progestational hormones > Side effects.
Catechol estrogens > Carcinogenicity.
Estrogen > Carcinogenicity.
Catechol estrogens > Side effects.
Estrogen > Side effects.
Contraception > Complications.
Menopause > Hormone therapy > Complications.
Chemical carcinogenesis.
Cancer > Risk factors.
Women > Diseases > Risk factors.
Oral contraceptives > Carcinogenicity.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820317506719
Table of Contents:
  • Preliminaries; CONTENTS; PREAMBLE; Combined Estrogen-Progestogen Contraceptives; Combined Estrogen-Progestogen Menopausal Therapy; ANNEXES; CUMULATIVE INDEX TO THE MONOGRAPHS SERIES;

Similar Items